Udayavni Special

ICMR issues advisory for use of Feluda paper strip test


PTI, Oct 23, 2020, 12:17 PM IST

 

New Delhi: The Indian Council of Medical Research (ICMR) has issued an advisory for the use of indigenously developed Feluda paper strip test, which is based on CRISPR-Cas9 technology for diagnosis of SARS-CoV-2, by laboratories.

The paper-strip uses cutting-edge CRISPR gene-editing technology to identify and target the genetic material of SARS-CoV-2, the virus that causes COVID-19 in less than an hour.

As claimed by the manufacturer, no further RT-PCR based confirmation is required for samples that are confirmed as positive or negative by the CRISPR SARS-CoV-2 test, the advisory issued on Thursday stated.

The test has been developed by the Council of Scientific and Industrial Research’s (CSIRs) Institute of Genomics and Integrative Biology (IGIB), Delhi, and has been validated by the National Centre for Biological Sciences and the Tata Institute of Fundamental Research.

The test has been approved by the Drugs Controller General of India (DCGI) for use in the country.

“The test works by identifying SARS-CoV-2 virus strain and uses a Thermal Cycler instead of a qPCR machine for conducting the test. As claimed by the manufacturer, no further RT-PCR based confirmation is required for samples that are confirmed as positives or negatives by the CRISPR SARS-CoV-2 test,” the ICMR said in its advisory.

Existing government or private laboratories already approved by the ICMR for SARS-CoV-2 RT-PCR based testing may use this new CRISPR test if the laboratory desires to do so.

No further approval is required from the ICMR for existing laboratories.

New laboratories intending to initiate molecular testing of SARS-CoV-2 testing by any method will be required to seek approval as per the standard process laid down by the ICMR and NABL before initiating any kind of molecular testing, the advisory said.

Any prescription for RT-PCR, CRISPR, TRUENAT, CBNAAT may be considered equivalent.

All testing data should be essentially entered into the ICMR COVID-19 web portal on a real time basis.

Union Health Minister Harsh Vardhan had recently said that based on tests in over 2,000 patients during the trials at the Institute of Genomics and Integrative Biology (IGIB) and testing in private labs, the tests showed 96 per cent sensitivity and 98 per cent specificity.

This compares favourably to ICMR’s current acceptation criteria of RT-PCR kit of at least 95 per cent sensitivity and at least 99 per cent specificity, he had stated.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

COVID-19 vaccine to be first given to about 1 cr health workers: Govt at all-party meet

Malaika multi-state credit society scam: Four top office-bearers held for duping investors

Maharashtra Teacher Wins $1 Million, Says Will Share Half With Finalists

War of words between CSE, FSSAI over adulterated honey sold by major brands in India

By when will every Indian get free COVID vaccine, Rahul Gandhi asks PM Modi

Hooliganism will not be allowed in Shivamogga: Eshwarappa

Met dept withdraws red alert for 7 Kerala districts as cyclone Burevi weakens



Related Articles More

15-yr-old Indian-American Gitanjali Rao named first ‘TIME Kid of the Year’

COVID-19 vaccine to be first given to about 1 cr health workers: Govt at all-party meet

By when will every Indian get free COVID vaccine, Rahul Gandhi asks PM Modi

Met dept withdraws red alert for 7 Kerala districts as cyclone Burevi weakens

DSGMC sends legal notice to Kangana Ranaut over ”derogatory” tweets against farmers

MUST WATCH

Hamsa Chaitanya Desi Outlet | Desi Products Store Udupi | Documentary by Udayavani

Pro-terror graffiti case culprits will be arrested soon: Basavaraj Bommai

Meal of Bakasur : Hotel Fish Campus Udupi | Udayavani

Things You Should Know When Starting A Business | Profitable Business Ideas After Lockdown

Mangalore Boat tragedy: We’re with families of deceased, says Kota after announcing Rs 6 lakh compensation

Latest Additions

Zydus Cadila Gets DGCI Nod for Phase 3 Covid Vaccine Clinical Trials with Biological Therapy

Joe Biden Taps Indian-American Vivek Murthy as Surgeon General: Report

15-yr-old Indian-American Gitanjali Rao named first ‘TIME Kid of the Year’

COVID-19 vaccine to be first given to about 1 cr health workers: Govt at all-party meet

Malaika multi-state credit society scam: Four top office-bearers held for duping investors

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.